Astrana Health (ASTH) vs Everforth (EFOR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Astrana Health (ASTH) has outperformed Everforth (EFOR) over the past year, gaining 22.5% versus a loss of 26.9%. Over five years, ASTH leads with a -48.0% price change compared with -70.6% for EFOR. Astrana Health is the larger company by market cap ($1.84 billion vs $1.43 billion), about 1.3 times the size.
On valuation, Everforth trades at a lower forward P/E (8.1x vs 10.2x for Astrana Health).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ASTH | EFOR |
|---|---|---|
| Share price | $37.14 | $34.91 |
| Market cap | $1.84B | $1.43B |
| 1-day change | +0.38% | -2.95% |
| YTD return | +49.70% | -27.53% |
| 1-year return | +22.45% | -26.86% |
| 5-year return | -48.05% | -70.59% |
| P/E ratio (TTM) | 44.75 | 17.99 |
| Forward P/E | 10.21 | 8.11 |
| EPS (TTM) | $0.83 | $1.94 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $51.60 | $54.94 |
| 52-week low | $18.08 | $16.90 |
| Distance from 52-week high | -28.02% | -36.46% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +39.12% | — |
| Average volume | 459.62K | 834.05K |
| Shares outstanding | 49.60M | 41.00M |
| Employees | 3,000 | — |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Industry | Professional Services | Professional Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ASTH has outperformed EFOR by 49.3 percentage points over the past year.
- Astrana Health trades at a higher earnings multiple (44.7x vs 18.0x trailing P/E).
About Astrana Health
ASTH stock →Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement.
Consumer Discretionary · Professional Services · 3,000 employees
ASTH vs EFOR FAQ
Which is bigger, Astrana Health or Everforth?
Astrana Health (ASTH) is larger, with a market capitalization of $1.84B compared with $1.43B for Everforth (EFOR).
Which stock has performed better over the past year, ASTH or EFOR?
ASTH returned +22.45% over the past 12 months, compared with -26.86% for EFOR (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, ASTH or EFOR?
EFOR has the lower trailing P/E at 18.0, versus 44.7 for ASTH. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are Astrana Health and Everforth in the same industry?
Yes. Both are classified in the Professional Services industry within the Consumer Discretionary sector.